19 research outputs found
Validation of Arxula Yeast Estrogen Screen assay for detection of estrogenic activity in water samples: Results of an international interlaboratory study
Detektion hormonell aktiver Substanzen im wirkungsrelevanten Konzentrationsbereich zur Beurteilung einer großtechnischen Abwasser Ozonung
Natürliche Hormone und Substanzen mit einer hormonellen Wirkung werden als organischen Spurenstoffen oder Mikroschadstoffe bezeichnet und werden über verschiedene Quellen in die Umwelt eingetragen. Dies führt insbesondere bei aquatischen Lebewesen zu Veränderungen im endokrinen System. Um die Belastung der Gewässer mit hormonell aktiven Substanzen zu verringern und einen guten chemischen und ökologischen Status nach europäischer Wasserrahmenrichtlinie zu erreichen, wird eine Reduktion des Eintrags hormonell aktiver Substanzen angestrebt. Die meisten Abwässer werden in Kläranlagen gesammelt, die somit Punktquellen für den Eintrag von hormonell aktiven Substanzen in die Umwelt darstellen. Zur Untersuchung neuer Methoden zur Abwasserreinigung sind zuverlässige und sensitive analytische Messtechniken notwendig. Da aktuelle instrumentelle Messmethoden nicht in der Lage sind hormonell aktive Substanzen im wirkungsrelevanten Konzentrationsbereich zu messen, wurden Hefezellenassays zur Detektion der östrogenen (A-YES) und androgenen (A-YAS) Aktivitäten für eine Anwendung in Oberflächengewässern und Abwässern evaluiert. Im Anschluss wurden diese Assays zur Beurteilung und Optimierung der Eliminationsleistung einer großtechnischen Ozonung auf einer kommunalen und einer Krankenhaus Kläranlage eingesetzt. Die untersuchten Abwassermatrices zeigten keine Effekte auf die Enzym Substrat Reaktion und die optische Dichte der A-YES Hefezellensuspension. Proben eines Oberflächengewässers sowie von Kläranlagen Zuläufen verursachten im A-YAS eine erhöhte optische Dichte der Zellsuspension im Vergleich zur Referenz. Eine verringerte optische Dichte der A-YAS Hefezellsuspension konnte in Extrakten von Zulaufproben bestimmt werden. Durch die Dotierung unterschiedlicher Konzentrationen der Referenzsubstanzen zu Oberflächengewässer- und Abwasserproben konnten Dosis Wirkungskurven mittels A-YES und A-YAS Assays abgebildet werden. Dabei konnte gezeigt werden, dass insbesondere in Kläranlagen-Zulaufproben sowohl eine östrogene als auch eine androgene Aktivität bereits in der undotierten Ausgangsprobe vorhanden war. Des Weiteren konnten inhibierende Effekte in den Proben detektiert werden, die auf antagonistische Substanzen hindeuten. Die Analyse von Kläranlagen Abläufen zeigte östrogene Aktivitäten zwischen 0,035 und 5,5 ng EEQ/L sowie androgene Aktivitäten zwischen < 0,31 und 6,1 ng DHTEQ/L. Während der großtechnischen Ozonung konnte die östrogene Aktivität in einer kommunalen sowie einer Krankenhaus Kläranlage um bis zu 97% bzw. 83% reduziert werden. Die Reduktion der androgenen Aktivität lag bei 80% und 66%. Für zwei Verfahren zur bedarfsabhängigen Steuerung der Ozonung basierend auf der östrogenen Aktivität und auf dem DOC Gehalt konnte die Machbarkeit gezeigt werden. Allerdings stellten sich beide Methoden zum jetzigen Zeitpunkt als nicht wirtschaftlich heraus. Antagonistische Aktivitäten konnten in einem Konzentrationsbereich von 330 - 2.700 µg OHTEQ/L (anti-östrogene Aktivität) und 550 - 730 µg FEQ/L (anti-androgene Aktivität) mittels anti A-YES und anti A-YAS detektiert werden. Während der einzelnen Reinigungsstufen konnte keine Reduktion der antagonistischen Aktivitäten nachgewiesen werden. Sowohl A-YES als auch A-YAS sind für die Analyse von Abwasserproben geeignet und ermöglichen so erstmals die Beurteilung von Verfahren zur Abwasserreinigung im wirkungsrelevanten Konzentrationsbereich.Natural hormones and hormonal active substances are organic micropollutants and enter the environment by different sources. They can affect especially aquatic organisms resulting in changes of the endocrine system. For the reduction of hormonal active compounds in surface waters and to achieve a good ecological and chemical status according to the Water Framework Directive the entry into the aquatic environment of these substances should be reduced. Most wastewaters are collected in wastewater treatment plants (WWTP) which act as point source of micropollutants into the environment. For evaluation of novel methods for wastewater treatment reliable and sensitive analytical methods are essential. As current analytical tools using instrumental methods are not able to detect hormonal active compounds in the effect relevant concentration range yeast cell assays for the detection of estrogenic (A-YES) and androgenic (A-YAS) activity were evaluated for their use in surface waters and wastewaters. Subsequently they were used for the evaluation of a full scale ozonation plant at a municipal and a hospital WWTP. Investigated matrices did not show effects on the enzyme-substrate reaction and to the optical density of the A-YES cell suspension. Surface water and WWTP influent samples increases optical density of the yeast cell suspension when compared to the reference water. Reduced optical density of A-YES cell suspension was detected in extracts of WWTP influents. Different concentrations of spiked reference substances results in dose response curves determined by the A-YES and A-YAS. Especially WWTP influent samples showed estrogenic and androgenic activity already in the unspiked sample. Additionally inhibitory effects were detected indicating antagonistic substances in the samples. Analysis of WWTP effluents showed estrogenic activity in the range of 0.035 5.5 ng EEQ/L and androgenic activity between < 0.31 and 6.1 ng DHTEQ/L. During a full scale ozonation estrogenic activity at a municipal and a hospital WWTP estrogenic activity was reduced up to 97% and 83%, respectively. Androgenic activity was reduced up to 80% and 66%. Both methods for demand depended control of ozonation based on estrogenic activity and DOC concentration were feasible but not applicable because of economic points of view up to now. Antagonistic activity was detected in the range of 330 - 2,700 µg OHTEQ/L (anti-estrogenic activity) and 550 - 730 µg FEQ/L (anti-androgenic activity) using anti A-YES and anti A-YAS. During treatment process antagonistic activity was not reduced. The A-YES and the A-YAS assays were suitable for the analysis of wastewater samples and firstly offer the assessment of processes for a further wastewater treatment in the effect relevant concentration range
Lithium medication in pregnancy and breastfeeding — a case series
Lithium salts are the first-line prophylaxis treatment for bipolar disorder in most guidelines. The majority of bipolar women are treated with mood stabilizers at the time they wish to get pregnant. One reason for this is the rising average age at first childbirth, at least in the high-income countries, which increases in general the likelihood of a medication with psychotropic drugs. Previously, lithium exposition during pregnancy was thought to strongly increase the risk of severe cardiac malformation. However, recent studies only point to a low teratogenic risk, so nowadays an increasing number of women are getting pregnant with ongoing lithium treatment. Regarding lithium medication during breastfeeding, there is evidence that lithium transfers to the breastmilk and can also be detected in the infants' serum. The influence on the infant is still a largely understudied topic. Regular monitoring of the infants' renal clearance, thyroid function, and lithium levels is warranted when breastfeeding under lithium exposure. In this case series, we present three case reports of bipolar mothers who were treated with lithium during pregnancy and breastfeeding to add to the scarce literature on this important topic. In short, we strengthen the importance of therapeutic drug monitoring due to fluctuating plasma levels during pregnancy and after birth, and we can report the birth and development of three healthy infants despite lithium medication during pregnancy and breastfeeding
Unique communities of anoxygenic phototrophic bacteria in saline lakes of Salar de Atacama (Chile): evidence for a new phylogenetic lineage of phototrophic Gammaproteobacteria from pufLM gene analyses
Phototrophic bacteria are important primary producers of salt lakes in the Salar de Atacama and at times form visible mass developments within and on top of the lake sediments. The communities of phototrophic bacteria from two of these lakes were characterized by molecular genetic approaches using key genes for the biosynthesis of the photosynthetic apparatus in phototrophic purple bacteria (pufLM) and in green sulfur bacteria (fmoA). Terminal restriction fragment length polymorphism of the pufLM genes indicated high variability of the community composition between the two lakes and subsamples thereof. The communities were characterized by the dominance of a novel, so far undescribed lineage of pufLM containing bacteria and the presence of representatives related to known halophilic Chromatiaceae and Ectothiorhodospiraceae. In addition, the presence of BChl b-containing anoxygenic phototrophic bacteria and of aerobic anoxygenic bacteria was indicated. Green sulfur bacteria were not detected in the environmental samples, although a bacterium related to Prosthecochloris indicum was identified in an enrichment culture. This is the first comprehensive description of phototrophic bacterial communities in a salt lake of South America made possible only due to the application of the functional pufLM genes
Psychotropic medication in pregnancy and lactation and early development of exposed children
There is still limited knowledge about alterations of blood concentrations of psychotropic drugs during pregnancy, the transfer of psychotropic drugs into breastmilk and the effects on exposed children. We investigated changes in concentrations of psychopharmacological medication during pregnancy and lactation in serum and breastmilk at different time points in a naturalistic sample of 60 mothers and observed the development of the exposed children in the first 12 months. We found a decrease in serum concentrations from the first to the second trimester of amitriptyline, duloxetine, escitalopram, quetiapine and sertraline. Citalopram stayed rather stable during pregnancy, sertraline levels interestingly increased again from the second to the third trimester. High concentration-by-dose ratios in breastmilk were found for venlafaxine as well as lamotrigine, low for quetiapine and clomipramine. Similarly, clomipramine and quetiapine showed low milk/serum–penetration ratios. Regarding the birth outcome measures in children, we found no significant differences between in utero exposed compared to nonexposed newborns. There were no significant differences in the development in the first 12 months. Psychotropic medication in the peripartum needs a balancing of risks and benefits and a continuous therapeutic drug monitoring can be a guidance for clinicians to monitor drug alteration patterns, which are likely to occur due to physiological pregnancy-associated changes in pharmacokinetics. Accordingly, therapeutic drug monitoring can optimize a medication in pregnancy and lactation with the lowest effective dose
Functional characterisation of rare variants in genes encoding the MAPK/ERK signalling pathway identified in long-lived Leiden Longevity Study participants
A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
The paracaspase mucosa-associated lymphoid tissue lymphoma translocation protein-1 (MALT1) regulates nuclear-factor-kappa-B (NF-κB) activation downstream of surface receptors with immunoreceptor tyrosine-based activation motifs (ITAMs), such as the B-cell or T-cell receptor and has thus emerged as a therapeutic target for autoimmune diseases. However, recent reports demonstrate the development of lethal autoimmune inflammation due to the excessive production of interferon gamma (IFN-ɣ) and defective differentiation of regulatory T-cells in genetically modified mice deficient in MALT1 paracaspase activity. To address this issue, we explored the effects of pharmacological MALT1 inhibition on the balance between T-effector and regulatory T-cells. Here we demonstrate that allosteric inhibition of MALT1 suppressed Th1, Th17 and Th1/Th17 effector responses, and inhibited T-cell dependent B-cell proliferation and antibody production. Allosteric MALT1 inhibition did not interfere with the suppressive function of human T-regulatory cells, although it impaired de novo differentiation of regulatory T-cells from naïve T-cells. Treatment with an allosteric MALT1 inhibitor alleviated the cytokine storm, including IFN-ɣ, in a mouse model of acute T-cell activation, and long-term treatment did not lead to an increase in IFN-ɣ producing CD4 cells or tissue inflammation. Together, our data demonstrate that the effects of allosteric inhibition of MALT1 differ from those seen in mice with proteolytically inactive MALT1, and thus we believe that MALT1 is a viable target for B and T-cell driven autoimmune diseases
Biological effect and chemical monitoring of Watch List substances in European surface waters: Steroidal estrogens and diclofenac – Effect-based methods for monitoring frameworks
International audienceThree steroidal estrogens, 17 alpha-ethinylestradiol (EE2), 17 beta-estradiol (E2), estrone (E1), and the non-steroidal anti-inflammatory drug (NSAID), diclofenac have been included in the first Watch List of the Water Framework Directive (WFD, EU Directive 2000/60/EC, EU Implementing Decision 2015/495). This triggered the need for more EU-wide surface water monitoring data on these micropollutants, before they can be considered for inclusion in the list of priority substances regularly monitored in aquatic ecosystems. The revision of the priority substance list of the WFD offers the opportunity to incorporate more holistic bioanalytical approaches, such as effect-based monitoring, alongside single substance chemical monitoring. Effect-based methods (EBMs) are able to measure total biological activities (e.g., estrogenic activity or cyxlooxygenase [COX]-inhibition) of specific group of substances (such as estrogens and NSAIDs) in the aquatic environment at low concentrations (pg/L). This makes them potential tools for a cost-effective and ecotoxicologically comprehensive water quality assessment. In parallel, the use of such methods could build a bridge from chemical status assessments towards ecological status assessments by adressing mixture effects for relevant modes of action. Our study aimed to assess the suitability of implementing EBMs in the WFD, by conducting a large-scale sampling and analysis campaign of more than 70 surface waters across Europe. This resulted in the generation of high-quality chemical and effect-based monitoring data for the selected Watch List substances. Overall, water samples contained low estrogenicity (0.01-1.3 ng E2-Equivalent/L) and a range of COX-inhibition activity similar to previously reported levels (12-1600 ng Diclofenac-Equivalent/L). Comparison between effect-based and conventional analytical chemical methods showed that the chemical analytical approach for steroidal estrogens resulted in more (76%) non-quantifiable data, i.e., concentrations were below detection limits, compared to the EBMs (28%). These results demonstrate the excellent and sensitive screening capability of EBMs
Investigation of full-scale ozonation at a municipal wastewater treatment plant using a toxicity-based evaluation concept
<p>Effluents from municipal wastewater treatment plants (WWTPs) are known to be point sources of micropollutants for surface waters. The aim of this study was to examine a reconstructed full-scale ozonation equipped with a pump-injector system for ozone (O<sub>3</sub>) dosage and a fluidized moving-bed reactor as biological posttreatment at a municipal WWTP utilizing an effect-directed approach. This approach consists of chemical analysis in combination with toxicological tests for the assessment of treatment efficiency of the plant. Chemical analysis showed elimination rates > 80% for pharmaceuticals and industrial chemicals. Analysis of endocrine disruptors was limited due to substance concentrations below the limit of detection (LOD). Estrogenic activity was detected by the <i>Arxula Adeninivorans</i> yeast estrogen screen (A-YES) at low concentrations (pg to ng EEQ/l range). Estrogenic activity was reduced by more than 90% after ozonation. In contrast, androgenic activity (measured in the <i>Adeninivorans</i> yeast androgen screen, A-YAS) was still found after O<sub>3</sub> treatment and after biological posttreatment, which is consistent with the data obtained by chemical analysis. Furthermore, no marked genotoxic or cytotoxic effects were observed after ozonation using the alkaline comet and 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid (MTT) assays, respectively. Results suggest that the applied specific O<sub>3</sub> dose of 0.4 mg<sub>O3</sub>/mg<sub>DOC</sub> is a safe operation setup in terms of toxicologically relevant transformation products. In addition, no adverse effects on primary producers, as evidenced by algae growth inhibition tests, were detected. The monitored biofilm growth in the biological posttreatment exhibited a steady state after one month. Based on computational fluid dynamics (CFD) simulations and biomass, one might conclude that O<sub>3</sub> did not apparently enter biological posttreatment to a great extent and that hydraulic retention time in the O<sub>3</sub> reactor was sufficient. Our data demonstrate the effectiveness of a full-scale O<sub>3</sub> treatment in combination with a fluidized moving-bed reactor as biological posttreatment for the reduction of a majority of micropollutants without the release of relevant toxic transformation products as assessed by a chemical and toxicity-based approach.</p